The Miller Lab The Miller Lab The Miller Lab
  • Our Approach
  • Meet The Team
  • Publications
  • Presentations
  • Posts
  • Software
  • Funding
  • Slides
  • Donate
2023
CME
CSCC
BCC
David M. Miller and Vishal Anil Patel discuss clinical considerations for immunotherapy in nonmelanoma skin cancers in this Medscape Education Oncology program.
Authors

David M. Miller

Vishal Anil Patel

Published

September 28, 2023

Medscape Education Oncology

Top 10 Clinical Pearls

Immunotherapy in Nonmelanoma Skin Cancers

SCCBCCImmunotherapy
ReleasedSeptember 28, 2023
FormatOnline enduring program
Original creditCME / ABIM MOC
Credit statusExpired September 28, 2024

Overview

David M. Miller and Vishal Anil Patel discuss clinical considerations for incorporating immunotherapy into care for patients with nonmelanoma skin cancers. The program addresses locally advanced SCC, multidisciplinary management, and treatment decisions in advanced BCC.

Faculty

  • David M. Miller, MD, PhD, FAAD
  • Vishal Anil Patel, MD

Program & resources

View Medscape program →

Download slides · Read activity transcript

Program support: Supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. Developed through a partnership between Medscape and the Society for Immunotherapy of Cancer.

Credit has expired. The activity was released September 28, 2023, and was valid for credit through September 28, 2024. Educational content reflects the original release date.

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement.